Back to overview

We are Galapagos

A pioneering biotech company. We create value through science.

We pioneer for patients

In our pursuit to discover, develop and deliver innovative medicines, we go where no one has ever gone before.

We dare, we care

As a hands-on company, our success is built on a culture of continuous scientific exploration, risk-taking, and speed of action for the benefit of patients.

  • Act as pioneers

    We don’t shy away from fundamental challenges.

  • Raise the bar

    We like to challenge each other to push the limits in every decision we make.

  • Embrace change

    We’re not afraid to fail, because a dead end can be changed into an opportunity.

  • Make it happen

    We’re proud of our responsibility to pioneer for patients.

We deliver our discoveries to patients

We want to become one of the leading biotech companies in the world. Headquartered in Mechelen, Galapagos employs over 800 people across Belgium, The Netherlands, France, Italy, Spain, the UK, Switzerland, the US, and Croatia.

Our people make it happen

We all have a crucial part to play in something far greater. Individually, as teams and as a company, we’re driven to never give up, pushing back the boundaries of what we know and think is possible. Because we know we can create a bigger impact by working together.

Get to know Galapagos in numbers

  • By 2020

    we want to become a fully integrated biopharma company.

  • 40+

    clinical studies. And very close to bringing our first medicine to market.

  • 400%

    We’re growing fast. From 2015 to 2019, we increased our clinical studies from 8 to 40.

  • 20 years

    ago, we started as an adventurous start-up founded by our CEO Onno van de Stolpe. Since then, we turned into an established international biotech player.

We’re just getting started

A new adventure will start in 2020. That future is very close, and you can make it happen. How are you going to help to get us there?

Join us in our purpose